Published dossiers
Published May 23, 2026 · Sentinel refresh May 26, 2026 · The HOLD-with-Storyteller-SELL dossier · Companion video on @TheAIRazor
NVIDIA scored 100/100 on the Occam Score and a Rule of 40 of 113 — among the highest the methodology has ever evaluated at this scale. The methodology still returned HOLD. Our DCF says $104.15 against a market price of $213.20 (Sentinel refresh 2026-05-26); a third-party DCF says $250.61. The 58.4% deviation between two reasonable DCFs is the largest in recent run history. Three lenses said HOLD; the Storyteller dissented with SELL and flagged four absences in NVIDIA's disclosures.
Jury split:
3 HOLD (Auditor, Architect, Sentinel)
1 SELL (Storyteller)
→ Final HOLD @ MEDIUM
Read the full NVDA dossier →
Published May 19, 2026 · The preserved-dissent dossier · Companion video on @TheAIRazor · Companion article on LinkedIn
Our DCF said STRONG BUY (+54%). Wall Street's DCF said SELL (-18%). Buffett-Lynch said HEALTHY Stalwart. Peers said DEEP_DISCOUNT. Three of four independent inputs agreed bullish. The 4-LLM Jury refused to synthesize and FLAGGED the disagreement instead. The dossier preserves all four lens narratives verbatim.
Jury split:
2 BUY (Auditor, Sentinel)
1 HOLD (Architect)
1 FLAGGED (Storyteller)
→ Final FLAGGED @ HIGH
Read the full QCOM dossier →
Published May 14, 2026 · Companion video forthcoming
Three of our four AI lenses said HOLD on OBDC. Then OBDC cut the dividend 16% on May 7, 2026. The same 0.82x NII coverage gap that drove the cut is what the methodology read as the primary risk vector. One lens pulled stale data and produced a now-falsified BUY — both reads stay on the record per the dissent-preservation discipline.
Jury split:
3 HOLD (Auditor, Architect, Storyteller)
1 BUY (Sentinel, stale-data)
→ Final HOLD @ MEDIUM
Read the full OBDC dossier →
Published May 14, 2026 · Companion video forthcoming
Excellent business. Problem price. All four lenses converge on overvaluation — DCF $123.33 against market $301.64, a 59% premium. The Architect lens returned FLAGGED on the structural tension between an Occam Score of 95 (HEALTHY classification) and a DCF that says STRONG SELL. The FLAGGED-override triggers the final hero verdict.
Jury split:
1 SELL (Auditor)
1 FLAGGED (Architect)
1 SELL (Storyteller)
1 STRONG SELL (Sentinel)
→ Final FLAGGED @ HIGH
Read the full MDB dossier →
Published May 11, 2026 · Updated May 12, 2026 · Companion video on @TheAIRazor
ELITE quality at a SELL price. DCF $515.19 against market price near $602. Occam Score 100 / Rule of 40 score 79.8. Two lenses called the price overstretched. One pushed back on the cross-references. One disagreed entirely on conviction. The dissent is preserved on the public record.
Jury split:
1 BUY (Auditor)
2 SELL (Architect, Storyteller)
1 HOLD (Sentinel)
→ Final HOLD @ MEDIUM
Read the full META dossier →
Published May 3, 2026 · Updated May 11, 2026 · Companion video on @TheAIRazor
Wall Street rated Alphabet 88% BUY at $402. The Forensic Jury reached SELL at $160 intrinsic value — a −51.5% margin of safety driven by the $91B annual CapEx hole and 60.8% terminal-value share of enterprise value. Three lenses converged. One pushed back on the post-Q1 analyst repricing.
Jury split:
3 SELL (Auditor, Architect, Storyteller)
1 HOLD (Sentinel)
→ Final SELL @ MEDIUM
Read the full GOOGL dossier →